- Research works
- 71 ▼ 43% vs 2013–17
- Citations
- 1.6k 22.1 per fractional work
- Top-10% rate
- 27.4% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: Pfizer (Australia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.7×. Every wedge is a field page.
- Immunology and Microbiology 10.7×
- Medicine 3.1×
- Business, Management and Accounting 2.2×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Health Professions 1.4×
- Neuroscience 1.1×
- Agricultural and Biological Sciences 0.9×
- Mathematics 0.8×
- Social Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.0×
Which keywords describe research at Pfizer (Australia)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Vaccine Development, Clinical Practice Guidelines, Drug Resistance, Clinical Trials, Vaccine and Genetics.
- Treatment Guidelines
- Antigen Presentation
- Pharmacokinetics
- Cost-effectiveness Analysis
- Zoonotic Transmission
- Global Trade
- Non-Communicable Diseases
- Human Metapneumovirus
- Anesthesia
- Targeted Therapy
- Host Immune Response
- Immunity
- Veterinary Parasites
- Anthelmintic Resistance
- Livestock
- Immune Response
- Drug Resistance
- Clinical Trials
- Clinical Practice Guidelines
- Antimicrobial Resistance
- Epidemiology
- Inflammation
- Vaccine Development
- Genetics
- Vaccine
- Pathogenesis
- Nematodes
- Disease Burden
- Cardiovascular Risk
- Community-Acquired Pneumonia
- Pneumococcal Conjugate Vaccine
- Vaccination
- Clinical Guidelines
- Respiratory Syncytial Virus
- Corporate Political Activity
- Virulence Factors
- Clinical Management
- Health Utility Measures
- Analgesia
- Postoperative Pain
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology15▲ 5.2×48 topics
- Antimicrobial Resistance4▲ 21×8 topics
- Inflammation4▲ 2.1×21 topics
- Clinical Practice Guidelines3▲ 8.3×8 topics
- Vaccine Development3▲ 15×8 topics
- Clinical Trials3▲ 6.9×9 topics
- Genetics3▲ 5.5×6 topics
- Drug Resistance3▲ 13×4 topics
- Vaccine3▲ 9.5×7 topics
- Immune Response2▲ 5.8×6 topics
- Pathogenesis2▲ 6.2×10 topics
- Livestock2▲ 47×2 topics
- Nematodes2▲ 54×2 topics
- Anthelmintic Resistance2▲ 134×1 topic
- Disease Burden2▲ 40×2 topics
- Veterinary Parasites2▲ 134×1 topic
- Cardiovascular Risk2▲ 8.5×4 topics
- Immunity2▲ 8.2×4 topics
- Community-Acquired Pneumonia2▲ 65×1 topic
- Host Immune Response2▲ 42×2 topics
- Pneumococcal Conjugate Vaccine2▲ 65×1 topic
- Targeted Therapy2▲ 12×3 topics
- Vaccination2▲ 35×2 topics
- Anesthesia2▲ 21×3 topics
- Clinical Guidelines2▲ 7.3×5 topics
- Human Metapneumovirus2▲ 48×1 topic
- Respiratory Syncytial Virus2▲ 48×1 topic
- Non-Communicable Diseases2▲ 14×2 topics
- Corporate Political Activity1▲ 69×1 topic
- Global Trade1▲ 14×1 topic
- Virulence Factors1▲ 10×3 topics
- Zoonotic Transmission1▲ 19×3 topics
- Clinical Management1▲ 8.9×2 topics
- Cost-effectiveness Analysis1▲ 23×1 topic
- Health Utility Measures1▲ 23×1 topic
- Pharmacokinetics1▲ 6.8×4 topics
- Analgesia1▲ 24×2 topics
- Antigen Presentation1▲ 18×2 topics
- Postoperative Pain1▲ 18×2 topics
- Treatment Guidelines1▲ 8.2×3 topics
Which research topics does Pfizer (Australia) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Pneumonia and Respiratory Infections, Influenza Virus Research Studies and Microbial infections and disease research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 1 works
- 2 Pneumonia and Respiratory Infections Epidemiology 1 works
- 3 Influenza Virus Research Studies Epidemiology 0 works
- 4 Microbial infections and disease research Microbiology 0 works
- 5 Milk Quality and Mastitis in Dairy Cows Agronomy and Crop Science 0 works
- 6 Appreciative Inquiry and Organizational Change Organizational Behavior and Human Resource Management 0 works
- 7 Hair Growth and Disorders Urology 0 works
- 8 Management and Organizational Studies Organizational Behavior and Human Resource Management 0 works
- 9 Healthcare Quality and Management Health Information Management 0 works
- 10 Bacterial Infections and Vaccines Microbiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (Australia)'s research output changed?
Output in 2018–2022 was 43% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.